Avecho Biotechnology Limited (ASX:AVE)
Australia
· Delayed Price · Currency is AUD 0.0040
0.00 (0.00%)
Jul 3, 2025, 3:00 PM AEST
Avecho Biotechnology Balance Sheet
Financials in millions AUD. Fiscal year is January - December.
Millions AUD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Cash & Equivalents | 2.37 | 5.5 | 1.47 | 3.26 | 1.87 | Upgrade
|
Cash & Short-Term Investments | 2.37 | 5.5 | 1.47 | 3.26 | 1.87 | Upgrade
|
Cash Growth | -56.86% | 274.90% | -55.03% | 74.33% | -41.67% | Upgrade
|
Accounts Receivable | 0.57 | - | - | 0.04 | 0.04 | Upgrade
|
Other Receivables | 1.68 | 1.1 | 0.75 | 1.09 | 0.44 | Upgrade
|
Receivables | 2.25 | 1.1 | 0.75 | 1.13 | 0.48 | Upgrade
|
Inventory | 0.14 | 0.1 | 0.4 | 0.2 | 0.1 | Upgrade
|
Prepaid Expenses | - | - | 0.23 | 0.22 | 0.24 | Upgrade
|
Other Current Assets | 0.05 | 0.3 | 0.01 | - | - | Upgrade
|
Total Current Assets | 4.81 | 7 | 2.85 | 4.81 | 2.69 | Upgrade
|
Property, Plant & Equipment | 0.17 | 0.32 | 0.47 | 0.34 | 0.23 | Upgrade
|
Other Intangible Assets | - | - | 0.03 | 0.1 | 0.43 | Upgrade
|
Other Long-Term Assets | 0.02 | - | - | - | - | Upgrade
|
Total Assets | 5 | 7.32 | 3.35 | 5.25 | 3.35 | Upgrade
|
Accounts Payable | 0.06 | 0.09 | 0.19 | 0.08 | 0.11 | Upgrade
|
Accrued Expenses | 0.56 | 0.49 | 0.46 | 0.42 | 0.35 | Upgrade
|
Short-Term Debt | 0.98 | - | - | - | - | Upgrade
|
Current Portion of Leases | 0.08 | 0.08 | 0.07 | 0.08 | 0.07 | Upgrade
|
Current Unearned Revenue | - | 0.16 | - | - | - | Upgrade
|
Other Current Liabilities | 0.02 | 0.02 | 0.02 | 0.12 | 0.07 | Upgrade
|
Total Current Liabilities | 1.71 | 0.84 | 0.75 | 0.7 | 0.6 | Upgrade
|
Long-Term Leases | 0.01 | 0.1 | 0.18 | 0.01 | 0.09 | Upgrade
|
Other Long-Term Liabilities | 0 | - | - | - | 0 | Upgrade
|
Total Liabilities | 1.73 | 0.94 | 0.92 | 0.71 | 0.7 | Upgrade
|
Common Stock | 244.61 | 244.61 | 237.53 | 237.6 | 232.78 | Upgrade
|
Retained Earnings | -269.39 | -267.44 | -264.1 | -262.07 | -258.66 | Upgrade
|
Comprehensive Income & Other | 28.06 | 29.21 | 29 | 29 | 28.54 | Upgrade
|
Shareholders' Equity | 3.27 | 6.38 | 2.42 | 4.54 | 2.65 | Upgrade
|
Total Liabilities & Equity | 5 | 7.32 | 3.35 | 5.25 | 3.35 | Upgrade
|
Total Debt | 1.08 | 0.18 | 0.25 | 0.09 | 0.17 | Upgrade
|
Net Cash (Debt) | 1.3 | 5.33 | 1.22 | 3.17 | 1.71 | Upgrade
|
Net Cash Growth | -75.65% | 336.06% | -61.46% | 85.80% | -45.19% | Upgrade
|
Net Cash Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | Upgrade
|
Filing Date Shares Outstanding | 3,169 | 3,169 | 1,838 | 1,838 | 1,829 | Upgrade
|
Total Common Shares Outstanding | 3,169 | 3,169 | 1,838 | 1,836 | 1,599 | Upgrade
|
Working Capital | 3.1 | 6.16 | 2.11 | 4.11 | 2.09 | Upgrade
|
Book Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | Upgrade
|
Tangible Book Value | 3.27 | 6.38 | 2.4 | 4.43 | 2.22 | Upgrade
|
Tangible Book Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | Upgrade
|
Machinery | - | - | - | 0.55 | 0.63 | Upgrade
|
Leasehold Improvements | - | - | - | 0.2 | - | Upgrade
|
Updated Mar 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.